Byington Carrie L
SEC CIK 1890265 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson | Dir | 5,018 | — | — | 6 | 2021-10-21 | 2026-01-27 |
Most active insiders at BDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| 2 | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| 3 | Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| 4 | SCOTT BERTRAM L | Dir | — | $212.3K |
| 5 | Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| 6 | Menziuso Peter | EVP, Pres, BDI | — | — |
| 7 | Roque Vitor | Interim CFO | — | — |
| 8 | Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| 9 | Shan David | EVP, Chief ISC Off | — | — |
| 10 | Waldstreicher Joanne | Dir | — | — |
| 13 | Byington Carrie L | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-29 | 2026-01-27 | BDX | Becton Dickinson | Byington Carrie L | Dir | A - Grant | $0.00 | +1,098 | 5,018 | +28% | $0 | |
| 2025-01-30 | 2025-01-28 | BDX | Becton Dickinson | Byington Carrie L | Dir | A - Grant | $0.00 | +930 | 3,834 | +32% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | Becton Dickinson | Byington Carrie L | Dir | A - Grant | $0.00 | +900 | 2,855 | +46% | $0 | |
| 2023-01-26 | 2023-01-24 | BDX | Becton Dickinson | Byington Carrie L | Dir | A - Grant | $0.00 | +848 | 1,924 | +79% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | Becton Dickinson | Byington Carrie L | Dir | A - Grant | $0.00 | +820 | 1,042 | +369% | $0 | |
| 2021-10-25 | 2021-10-21 | BDX | Becton Dickinson | Byington Carrie L | Dir | A - Grant | $0.00 | +221 | 221 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations